Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Holding in Top 10
Increase
Decrease
Funds Holding
2,276
Funds Holding Change
+2,276
Funds Holding Growth
–
Value
$715B
Holding in Top 10
1,048
Top 10 Change
+1,048
Top 10 Growth
–
Value Growth
–
New
2,276
Increased
–
Reduced
–
Closed
–
Capital Inflow
$722B
Capital Outflow
$0
Net Capital Flow
+$722B
Capital Flow Change
+$722B
Calls
$8.67B
Puts
$9.63B
Net Calls
-$958M
Put/Call Ratio
1.11